Overview
Distal hereditary motor neuropathy, Jerash type (also known as dHMN Jerash type or DSMA2) is a rare inherited neuromuscular disorder first described in families from the Jerash region of Jordan. It belongs to the group of distal hereditary motor neuropathies (dHMN), which are characterized by progressive weakness and wasting (atrophy) of muscles in the distal parts of the limbs — particularly the hands and feet. Unlike some other motor neuropathies, the Jerash type is distinguished by the presence of upper motor neuron signs, including pyramidal tract involvement with brisk reflexes and extensor plantar responses (Babinski sign), in addition to the lower motor neuron features of distal muscle weakness and atrophy. The disease typically presents in childhood or adolescence with progressive difficulty walking due to weakness and wasting of the lower leg muscles, often leading to foot drop and a steppage gait. Over time, the hands may also become affected, causing difficulty with fine motor tasks. Sensory function is generally preserved, distinguishing this condition from other hereditary neuropathies such as Charcot-Marie-Tooth disease. The combination of lower motor neuron signs (muscle wasting, weakness) with upper motor neuron signs (spasticity, hyperreflexia) can sometimes lead to diagnostic confusion with juvenile amyotrophic lateral sclerosis, though the Jerash type follows a much slower and more benign course. The condition is caused by mutations in the SIGMAR1 gene (also known as the sigma non-opioid intracellular receptor 1 gene) on chromosome 9p13. It follows an autosomal recessive inheritance pattern. There is currently no cure or disease-modifying treatment available. Management is supportive and symptomatic, including physical therapy, occupational therapy, orthotic devices (such as ankle-foot orthoses) to assist with mobility, and regular monitoring by a multidisciplinary team including neurologists and rehabilitation specialists.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Distal hereditary motor neuropathy, Jerash type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Distal hereditary motor neuropathy, Jerash type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Distal hereditary motor neuropathy, Jerash type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Distal hereditary motor neuropathy, Jerash type.
Community
No community posts yet. Be the first to share your experience with Distal hereditary motor neuropathy, Jerash type.
Start the conversation →Latest news about Distal hereditary motor neuropathy, Jerash type
No recent news articles for Distal hereditary motor neuropathy, Jerash type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Distal hereditary motor neuropathy, Jerash type
What is Distal hereditary motor neuropathy, Jerash type?
Distal hereditary motor neuropathy, Jerash type (also known as dHMN Jerash type or DSMA2) is a rare inherited neuromuscular disorder first described in families from the Jerash region of Jordan. It belongs to the group of distal hereditary motor neuropathies (dHMN), which are characterized by progressive weakness and wasting (atrophy) of muscles in the distal parts of the limbs — particularly the hands and feet. Unlike some other motor neuropathies, the Jerash type is distinguished by the presence of upper motor neuron signs, including pyramidal tract involvement with brisk reflexes and extens
How is Distal hereditary motor neuropathy, Jerash type inherited?
Distal hereditary motor neuropathy, Jerash type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Distal hereditary motor neuropathy, Jerash type typically begin?
Typical onset of Distal hereditary motor neuropathy, Jerash type is childhood. Age of onset can vary across affected individuals.